Actively Recruiting
Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatography Pancreatitis.
Led by GCS Ramsay Santé pour l'Enseignement et la Recherche · Updated on 2025-12-03
1800
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is, in a population of patients undergoing ERCP surgery, treated preventively with NSAIDs and divided into two groups according to the absence (group 1) or presence (group 2) of intravenous lidocaine in the general anesthesia protocol. The main objective of this study is to compare the incidence of post-ERCP pancreatitis between the two groups. type of study: clinical trial participant population/health conditions: Patients with ERCP surgery
CONDITIONS
Official Title
Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatography Pancreatitis.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 18 years of age
- Patient who has read and signed the consent form for participation in the study
- Patient candidate for ERCP with virgin papilla
You will not qualify if you...
- Patient with sphincterotomized papilla
- Patient under court protection, guardianship or curatorship
- Pregnant woman or woman of childbearing age without highly effective contraception for the duration of the study
- Patient not affiliated with the French social security system
- Patient participating in another clinical research protocol
- Inability to provide informed information and/or written consent (e.g., dementia, psychosis, disorders of consciousness, non-French speaking)
- Contraindication to the use of NSAIDs
- Contraindication to anesthesia or administration of any products used in anesthesia protocols, including lidocaine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital Privé des Peupliers
Paris, France, 75013
Actively Recruiting
Research Team
G
Gianfranco DONATELLI, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here